Asaraldehyde

Asaraldehyde

SCHEMBL333451

COc1cc(OC)c(OC)cc1C=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 1.00
KDM4E B2RXH2 2/20 1.00
TSHR P16473 2/20 1.00
TDP1 Q9NUW8 1/20 1.00
PRKDC P78527 2/20 0.65
CYP3A4 P08684 2/20 0.58
HMGCR P04035 1/20 0.58
MAPT P10636 2/20 0.57
ALOX15 P16050 1/20 0.57
HSD17B10 Q99714 1/20 0.57
LMNA P02545 1/20 0.57
HPGD P15428 1/20 0.57
NFE2L2 Q16236 1/20 0.55
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
NOD2 Q9HC29 2/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
ERN1 O75460 3/20 0.48
CYP1A1 P04798 2/20 0.48
CYP1B1 Q16678 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Asaraldehyde SCHEMBL29456596 1.00 ALDH1A1 (1.00) ALDH1A1KDM4ETSHRTDP1PRKDC
Asaraldehyde SCHEMBL27489564 0.98 ALDH1A1 (0.95) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL3136850 0.95 ALDH1A1 (0.90) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL10849623 0.92 ALDH1A1 (0.86) ALDH1A1KDM4ETSHRTDP1PRKDC
Asaraldehyde SCHEMBL28292329 0.91 ALDH1A1 (0.83) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL5698339 0.90 ALDH1A1 (0.81) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL9915849 0.88 ALDH1A1 (0.78) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL2761533 0.86 ALDH1A1 (0.74) ALDH1A1KDM4ETSHRTDP1PRKDC
SCHEMBL30865007 0.86 ALDH1A1 (0.75) ALDH1A1KDM4ETSHRTDP1PRKDC
2,4,6-Trimethoxybenzaldehyde SCHEMBL8703974 0.84 ALDH1A1 (0.71) ALDH1A1KDM4ETSHRTDP1PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1262 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4615506-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES Sahin, Fikret (TR) 2025-09-17 EP claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
US-12209232-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2025-01-28 US claimed
WO-2024258363-A1 USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES SAHIN FIKRET (TR) 2024-12-19 WO claimed
EP-4438065-A2 A MIXTURE COMPRISING 1,2-ALKANEDIOLS Symrise AG (DE) 2024-10-02 EP claimed
CN-117988111-A Preparation method of anti-fading antibacterial fabric 孔祥文 2024-05-07 CN claimed
US-11918671-B2 Multi-tone hair dyeing method in three steps HENKEL AG & CO. KGAA (DE) 2024-03-05 US claimed
US-20230340375-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2023-10-26 US claimed
EP-4229639-A1 METHOD AND SYSTEMS FOR PHYTOMEDICINE ANALYTICS FOR RESEARCH OPTIMIZATION AT SCALE GBS Global Biopharma, Inc. (CA) 2023-08-23 EP claimed
US-11732222-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2023-08-22 US claimed
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments ALLERGAN, INC. 2003-07-03 US claimed
US-6544390-B2 Oxidizing phenylpropene derivatives in presence of an oxidizing agent and cocatalyst in a solvent; under microwave radiation, removing the solvent under reduced pressure and isolating the product COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2003-04-08 US claimed
US-20020153240-A1 Microwave assisted rapid and economical process for the preparation of substituted phenylaldehydes from trans and cis-phenylpropenes: a commercial utilisation of toxic cis-isomer COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2002-10-24 US claimed
WO-2002079132-A1 MICROWAVE ASSISTED PROCESS FOR THE PREPARATION OF SUBSTITUTED PHENYLALDEHYDES FROM TRANS AND CIS-PHENYLPROPENES COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2002-10-10 WO claimed
US-6458168-B1 Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative L'OREAL S.A. (FR) 2002-10-01 US claimed
US-6451067-B1 HAIR DYE MIXTURE L'OREAL S.A. (FR) 2002-09-17 US claimed
US-5663029-A DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS XEROX CORPORATION (US) 1997-09-02 US claimed
US-4545870-A TRIALKOXYBENZALDEHYDES AND ORGANIC ACID COLUMBIA CHEMICAL CORPORATION (US) 1985-10-08 US claimed
EP-0006458-B1 N1-BENZOYL-N2-PHENYL-1,3-DIAMINOPROPANE-2-OLS AND THEIR SALTS, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM Kali-Chemie Pharma GmbH (DE) 1981-10-07 EP claimed
US-4271193-A PROPHYLAXIS AND TREATMENT OF GASTRITIS KALI-CHEMIE PHARMA GMBH (DE) 1981-06-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030124157-A1 Compositions containing aromatic aldehydes and their use in treatments TYR, ALDH2, AOX1 ALDH1A1 4/4885KDM4E 2261/4885TSHR 4387/4885
US-11918671-B2 Multi-tone hair dyeing method in three steps TYR, HAO2, HAAO ALDH1A1 111/4885KDM4E 1526/4885TSHR 3526/4885
US-20020153240-A1 Microwave assisted rapid and economical process for the preparation of substituted phenylaldehydes from trans and cis-phenylpropenes: a commercial utilisation of toxic cis-isomer PTMA, HDAC10, PSMB10 ALDH1A1 216/4885KDM4E 2524/4885TSHR 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.